Verifying…
Home / Drug A–Z / EM-B-PLEX Syrup## (Strength format)

EM-B-PLEX Syrup## (Strength format)

NAFDAC Reg. No. 04-0287 · Drug

Registered with NAFDAC — registration activeAs of 5 November 2026 · synced automatically from official sources.
Product
EM-B-PLEX Syrup## (Strength format)
NAFDAC number
04-0287
Active ingredient
Thiamine Hydrochloride; Riboflavin; Pyridoxine Hydrochloride; Niacinamide
Strength
see Composition
Form
Syrup
Pack size
1 x 100 mL (in glass bottle)
Manufacturer
Not listed
Applicant (holder)
Emzor Pharmaceutical Industries Limited
Approved
28 Mar 2023
Status
Active View on NAFDAC ↗
Registration valid to
27 Mar 2028
WHO alerts
None found
Community reports
None
Times checked
0

RxVerify commentary

  • EM-B-PLEX Syrup## (Strength format) is on the NAFDAC register with an active registration (04-0287). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.

What EM-B-PLEX Syrup## (Strength format) is used for

From the official U.S. FDA label for thiamine hydrochloride, the active ingredient registered with NAFDAC.

What it is used for

INDICATIONS Thiamine hydrochloride injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety. Thiamine hydrochloride injection should be used where rapid restoration of thiamine is necessary, as in Wernicke's encephalopathy, infantile beriberi with acute collapse, cardiovascular disease due to thiamine deficiency, or neuritis of pregnancy if vomiting is severe. It is also indicated when giving IV dextrose to individuals with marginal thiamine status to avoid precipitation of heart failure. …

Possible side effects

An occasional individual may develop a hypersensitivity or life threatening anaphylactic reaction to thiamine, especially after repeated injections. Collapse and death have been reported. A feeling of warmth, pruritus, urticaria, weakness, sweating, nausea, restlessness, tightness of the throat, angioneurotic edema, cyanosis, pulmonary edema, and hemorrhage into the gastrointestinal tract have also been reported. Some tenderness and induration may follow IM use (see WARNINGS ).

Do not use if

CONTRINDICATIONS A history of sensitivity to thiamine or to any of the ingredients in this drug is a contraindication. (See WARNINGS for further information.)

Warnings

WARNING: This product contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum. Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration. …

General information only — not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of EM-B-PLEX Syrup## (Strength format)

Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.

3 free checks left today · no signup Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About EM-B-PLEX Syrup## (Strength format)

What is in EM-B-PLEX Syrup## (Strength format)?

EM-B-PLEX Syrup## (Strength format) contains Thiamine Hydrochloride; Riboflavin; Pyridoxine Hydrochloride; Niacinamide (see Composition), as syrup, according to its NAFDAC registration record.

Is EM-B-PLEX Syrup## (Strength format) registered with NAFDAC?

Yes. EM-B-PLEX Syrup## (Strength format) is listed on the NAFDAC register under registration number 04-0287, and its registration is active as of 5 November 2026.

Has EM-B-PLEX Syrup## (Strength format) been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches EM-B-PLEX Syrup## (Strength format) in our automatically synced alert list.

How can I check that my pack of EM-B-PLEX Syrup## (Strength format) is genuine?

Run a free authenticity scan with the NAFDAC number 04-0287, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is EM-B-PLEX Syrup## (Strength format) used for?

INDICATIONS Thiamine hydrochloride injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety. Thiamine hydrochloride injection should be used where rapid restoration of thiamine is necessary, as in Wernicke's encephalopathy, infantile beriberi wit (Summarised from the official U.S. FDA label for thiamine hydrochloride. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used EM-B-PLEX Syrup## (Strength format)? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.